• English (United Kingdom)
  • Italiano (Italia)
    • + Increase
    • - Decrease
    • = Normal
    • Default mode
    • High Contrast
    • High Contrast
    • Aa
Registro Tumori Veneto
  • Home
  • About us
    • Introduction
    • Staff
    • Population and area
    • Statement
    • News
    • Mesotelioma Registry
      • Governance
        • Methods
        • Statement
      • Activities
      • Staff
      • Publications
  • Data
    • Veneto Data
    • Tumour site data
    • ULSS Data
  • Publications
    • Research publications
    • Meetings
      • Oral presentations
      • Posters
  • Links
  • Contacts
Registro Tumori Veneto
  • Home
  • About us
    • Introduction
    • Staff
    • Population and area
    • Statement
    • News
    • Mesotelioma Registry
      • Governance
        • Methods
        • Statement
      • Activities
      • Staff
      • Publications
  • Data
    • Veneto Data
    • Tumour site data
    • ULSS Data
  • Publications
    • Research publications
    • Meetings
      • Oral presentations
      • Posters
  • Links
  • Contacts
  • Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study

  • Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe

  • Cancer cure for 32 cancer types: results from the EUROCARE-5 study

  • Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study

  • Economic evaluation of cancer registration in Europe

  • Embryonal cancers in Europe

  • Epidemiology of glial and non-glial brain tumours in Europe

  • Epidemiology of rare cancers and inequalities in oncologic outcomes

  • Geographical variability in survival of European children with central nervous system tumours

  • Incidence and survival of rare urogenital cancers in Europe

  • Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002

  • Incidence, survival and prevalence of myeloid malignancies in Europe

  • Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting

  • Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project

  • Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study

  • Rare cancers are not so rare: the rare cancer burden in Europe

  • Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting

  • Rare thoracic cancers, including peritoneum mesothelioma

  • Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study

  • Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: results from EUROCARE-5

Page 1 of 2

  • Start
  • Prev
  • 1
  • 2
  • Next
  • End

Copyright © Registro Tumori Veneto 2018

Powered by ict4Life 

Privacy Policy

Joomla Templates by Joomla-Monster.com
Back to top